Abstract

In this work we describe a simple method to synthesis novel 3-[(pyridine-2-ylamino)methyl]-1,6-dihydro-1,2,4-triazine-5(2H)-one (3) and 1-(N-pyridine-2-ylglycyl)-1,2-diazepine-3,7-dione (4). Firstly, adding ethyl chloroacetate to a solution of KOH and 2-amionpyrdine and refluxed in absolute ethanol for 5 hours afforded the target ethyl-N-pyridin-2-ylglycinate (1), then refluxing of compound (1) with hydrazine hydrate in absolute ethanol for 6 hours yield 2-(pyridine-2-ylamino)acetohydrazide (2). Chloroacetamid and glutaric acid were refluxed with compound (2) in absolute ethanol for 20 and 21 hours to afford the compounds 3-[(pyridine-2-ylamino)methyl]-1,6-dihydro-1,2,4-triazine-5(2H)-one (3) and 1-(N-pyridine-2-ylglycyl)-1,2-diazepine-3,7-dione (4), respectively. Structures of the synthesized compounds were supported by means of FTIR, CHN elemental analysis, and NMR (1H, 13C) spectroscopic analysis. The synthesized compounds were evaluated for their in vitro antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Bacillus cereus, and Enterococcus faecalis. The inhibition zones were measured, expressed in mm, and the minimum inhibitory concentration (MIC) is reported in μg/mL. The results show that compounds (3) and (4) have a significant antimicrobial activity with the highest MIC value against all tested bacteria.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.